Benzoctamine

This classification denotes an anxiolytic with the molecular formula C18H19N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 734MM7Y191, chemically known as 9,10-ethanoanthracene-9(10h)-methylamine, n-methyl-, 9,10-dihydro but generally known as benzoctamine, which bears US NIH Compound Identifier 28425. Benzoctamine most often comes in base and hydrochloride forms. European Medicines Agency schedules Benzoctamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05757MIG. The term BENZOCTAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules benzoctamine in its Anatomical Therapeutic Chemical (ATC) Classification. BENZOCTAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benzoctamine under HS 29214980 and SITC 51454. As of Q4 2014, BENZOCTAMINE remains the US FDA Preferred Term for this commodity. Benzoctamine bears US NLM identifiers UMLS ID C0053217 and NCI Concept Code C83545. SMILES: N(CC12CCC(C3C1CCCC3)C1C2CCCC1)C.